Compare LYG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LYG | BSX |
|---|---|---|
| Founded | 1695 | 1979 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.5B | 137.8B |
| IPO Year | N/A | 2010 |
| Metric | LYG | BSX |
|---|---|---|
| Price | $5.25 | $71.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 20 |
| Target Price | N/A | ★ $109.15 |
| AVG Volume (30 Days) | ★ 25.7M | 12.8M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $13.39 | $12.04 |
| Revenue Next Year | $7.12 | $10.48 |
| P/E Ratio | $62.13 | ★ $36.74 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $3.27 | $70.75 |
| 52 Week High | $6.34 | $109.50 |
| Indicator | LYG | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 36.22 | 33.48 |
| Support Level | $4.39 | N/A |
| Resistance Level | $5.54 | $76.77 |
| Average True Range (ATR) | 0.13 | 1.76 |
| MACD | -0.07 | 0.31 |
| Stochastic Oscillator | 21.11 | 25.43 |
Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK. Insurance and wealth round out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset management services.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.